SG11202112487QA - Collagen peptide-based medicament compositions and devices and methods of production and use thereof - Google Patents
Collagen peptide-based medicament compositions and devices and methods of production and use thereofInfo
- Publication number
- SG11202112487QA SG11202112487QA SG11202112487QA SG11202112487QA SG11202112487QA SG 11202112487Q A SG11202112487Q A SG 11202112487QA SG 11202112487Q A SG11202112487Q A SG 11202112487QA SG 11202112487Q A SG11202112487Q A SG 11202112487QA SG 11202112487Q A SG11202112487Q A SG 11202112487QA
- Authority
- SG
- Singapore
- Prior art keywords
- production
- methods
- devices
- collagen peptide
- medicament compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6435—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a connective tissue peptide, e.g. collagen, fibronectin or gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962836934P | 2019-04-22 | 2019-04-22 | |
| US201962933685P | 2019-11-11 | 2019-11-11 | |
| US202062959282P | 2020-01-10 | 2020-01-10 | |
| PCT/US2020/029212 WO2020219486A2 (en) | 2019-04-22 | 2020-04-22 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202112487QA true SG11202112487QA (en) | 2021-12-30 |
Family
ID=72941814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202112487QA SG11202112487QA (en) | 2019-04-22 | 2020-04-22 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11389513B2 (en) |
| EP (1) | EP3958889A4 (en) |
| JP (1) | JP2022530402A (en) |
| KR (1) | KR20220031946A (en) |
| CN (1) | CN113795273A (en) |
| AU (1) | AU2020262096A1 (en) |
| BR (1) | BR112021021242A2 (en) |
| CA (1) | CA3132550A1 (en) |
| MX (1) | MX2021012579A (en) |
| SG (1) | SG11202112487QA (en) |
| WO (1) | WO2020219486A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113527468A (en) * | 2021-08-03 | 2021-10-22 | 上海胶媚商贸有限公司 | Collagen tripeptide structure for promoting skin, bone and muscle functions |
| WO2024006771A2 (en) * | 2022-06-27 | 2024-01-04 | Sustain Holdings, Llc | Collagen peptide-based medicament compositions and uses thereof |
| CN115851914A (en) * | 2022-12-12 | 2023-03-28 | 复旦大学附属眼耳鼻喉科医院 | Application of LOC107985869 in preparation of ophthalmoplegia specific auxiliary diagnostic reagent |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3283414A (en) | 1964-03-04 | 1966-11-08 | Chavanoz Moulinage Retorderie | Thermal treatment of synthetic textiles |
| US3883964A (en) | 1974-07-05 | 1975-05-20 | Olin Corp | Ski boot with adjustable instep plate |
| US5252608A (en) | 1988-02-25 | 1993-10-12 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US5120764A (en) | 1988-11-01 | 1992-06-09 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| FR2667981A1 (en) | 1990-10-12 | 1992-04-17 | Thomson Csf | METHOD OF ASSEMBLING TWO LAYERS CONSISTING OF DIFFERENT MATERIALS AND ITS APPLICATION TO HERMETIC ENCAPSULATION OF HYBRID CIRCUITS. |
| US5973112A (en) | 1997-08-25 | 1999-10-26 | Wisconsin Alumni Research Foundation | Collagen mimics |
| US6197934B1 (en) | 1998-05-22 | 2001-03-06 | Collagenesis, Inc. | Compound delivery using rapidly dissolving collagen film |
| US6946440B1 (en) | 1999-09-15 | 2005-09-20 | Dewoolfson Bruce H | Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
| BRPI0409376A (en) | 2003-04-15 | 2006-04-25 | Inflazyme Pharm Ltd | indene derivatives as pharmaceutical agents |
| WO2005000872A2 (en) | 2003-06-23 | 2005-01-06 | Wisconsin Alumni Research Foundation | Collagen mimics |
| WO2007044026A2 (en) | 2004-11-23 | 2007-04-19 | The Johns Hopkins University | Compositions comprising modified collagen and uses therefore |
| US9623129B2 (en) | 2005-09-26 | 2017-04-18 | Snip Holdings, Inc. | Methods and therapies for treating inflammatory conditions with exposed collagen |
| WO2007139914A2 (en) | 2006-05-26 | 2007-12-06 | Wisconsin Alumni Research Foundation | Collagen mimics |
| ES2402334T3 (en) | 2007-08-02 | 2013-04-30 | Gilead Biologics, Inc | Procedures and compositions for the treatment and diagnosis of fibrosis |
| US7858741B2 (en) | 2008-02-06 | 2010-12-28 | Wisconsin Alumni Research Foundation | Stabilization of the collagen triple helix by O-methylation of hydroxyproline residues |
| US9107935B2 (en) | 2009-01-06 | 2015-08-18 | Gilead Biologics, Inc. | Chemotherapeutic methods and compositions |
| US9259485B2 (en) | 2009-07-30 | 2016-02-16 | Fujifilm Corporation | Kidney-imaging agent comprising recombinant gelatin |
| EP2389939A1 (en) | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions |
| MX2012009088A (en) | 2010-02-04 | 2012-12-05 | Gilead Biologics Inc | Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor. |
| WO2011163574A1 (en) | 2010-06-25 | 2011-12-29 | Dewoolfson Bruce H | Device and method for the controlled delivery of ophthalmic solutions |
| US9289396B2 (en) | 2010-08-02 | 2016-03-22 | Euclid Systems Corporation | Collagen-based implants for sustained delivery of drugs |
| US9056923B2 (en) | 2010-12-10 | 2015-06-16 | The Johns Hopkins University | Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases |
| WO2013078091A1 (en) | 2011-11-22 | 2013-05-30 | The Johns Hopkins University | Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic use |
| US9255086B2 (en) | 2012-02-16 | 2016-02-09 | New York University | Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics |
| WO2015116646A1 (en) | 2014-01-28 | 2015-08-06 | Mccoy Enterprises, Llc | Collagen permeated medical implants |
| US9988434B2 (en) | 2014-09-12 | 2018-06-05 | Wisconsin Alumni Research Foundation | Optimal interstrand bridge for collagen mimics |
| KR101721059B1 (en) | 2014-12-26 | 2017-03-30 | 주식회사 아이바이오코리아 | Pharmaceutical composition for preventing or treating ocular surface disease |
| WO2016165788A1 (en) | 2015-04-14 | 2016-10-20 | Uab Ferentis | Collagen mimetic peptide |
| US10632168B2 (en) * | 2017-04-06 | 2020-04-28 | Sustain Holdings, Llc | Collagen peptide-based medicament compositions and devices and methods of production and use thereof |
| WO2024006771A2 (en) * | 2022-06-27 | 2024-01-04 | Sustain Holdings, Llc | Collagen peptide-based medicament compositions and uses thereof |
-
2020
- 2020-04-22 JP JP2021562953A patent/JP2022530402A/en active Pending
- 2020-04-22 BR BR112021021242A patent/BR112021021242A2/en unknown
- 2020-04-22 WO PCT/US2020/029212 patent/WO2020219486A2/en unknown
- 2020-04-22 AU AU2020262096A patent/AU2020262096A1/en active Pending
- 2020-04-22 CA CA3132550A patent/CA3132550A1/en active Pending
- 2020-04-22 SG SG11202112487QA patent/SG11202112487QA/en unknown
- 2020-04-22 CN CN202080030731.4A patent/CN113795273A/en active Pending
- 2020-04-22 EP EP20793550.3A patent/EP3958889A4/en active Pending
- 2020-04-22 MX MX2021012579A patent/MX2021012579A/en unknown
- 2020-04-22 KR KR1020217037786A patent/KR20220031946A/en unknown
- 2020-04-22 US US16/855,097 patent/US11389513B2/en active Active
-
2022
- 2022-06-30 US US17/854,986 patent/US20230048200A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022530402A (en) | 2022-06-29 |
| EP3958889A2 (en) | 2022-03-02 |
| EP3958889A4 (en) | 2022-12-28 |
| WO2020219486A2 (en) | 2020-10-29 |
| WO2020219486A3 (en) | 2020-12-03 |
| KR20220031946A (en) | 2022-03-14 |
| WO2020219486A9 (en) | 2021-07-08 |
| US11389513B2 (en) | 2022-07-19 |
| CA3132550A1 (en) | 2020-10-29 |
| CN113795273A (en) | 2021-12-14 |
| AU2020262096A1 (en) | 2021-11-04 |
| MX2021012579A (en) | 2021-11-12 |
| US20200353056A1 (en) | 2020-11-12 |
| BR112021021242A2 (en) | 2021-12-21 |
| US20230048200A1 (en) | 2023-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201906548B (en) | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | |
| EP3247324A4 (en) | Oral care compositions and methods of use | |
| IL281082A (en) | Compositions of cxcr4 inhibitors and methods of preparation and use | |
| EP3209681A4 (en) | Pharmaceutical compositions comprising peptide variants and methods of use thereof | |
| EP3283049A4 (en) | Oral care compositions and methods of use | |
| IL285008A (en) | Methods for the production and use of myceliated amino acid-supplemented food compositions | |
| EP3694603A4 (en) | Esophageal tissue and/or organoid compositions and methods of making same | |
| SG11202112487QA (en) | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | |
| EP3682884A4 (en) | Crystal form of gsk1278863 and preparation method and pharmaceutical use thereof | |
| EP3688011A4 (en) | Peptide compositions and methods of use thereof | |
| EP3638331A4 (en) | Three dimensional tissue compositions and methods of use | |
| IL269901B (en) | Pharmaceutical compositions and methods of treating cardiovascular diseases | |
| EP3606493A4 (en) | Dental cement compositions and methods of use | |
| EP3592227A4 (en) | Methods and systems to measure and evaluate stability of medical implants | |
| IL276135A (en) | Compositions and methods of use | |
| ZA202100780B (en) | Bismuth-thiol compositions and methods of use | |
| IL274578A (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| SG11202100533VA (en) | Hepato-biliary-pancreatic tissues and methods of making same | |
| EP3525787A4 (en) | Methods of treatment and pharmaceutical compositions using bcn057 or bcn512 | |
| EP3880183A4 (en) | Pharmaceutical preparation of fruquintinib and use thereof | |
| IL272495A (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| EP3592377A4 (en) | Dosage forms of tissue kallikrein 1 | |
| EP3612185A4 (en) | Pharmaceutical compositions comprising poh derivatives and methods of use | |
| AU2019903522A0 (en) | Pharmaceutical Compositions and Methods of Use | |
| IL291538A (en) | Anti-aging compositions and methods of use thereof |